IHS Chemical Week

Regions :: Western Europe :: Belgium

Solvay Raises Offer for Biotech Firm

9:03 AM MDT | July 9, 2008 | Kerri Walsh

Solvay says it has increased its offer to acquire biotechnological firm Innogenetics (Gent, Belgium) from €5.75/share in cash, to €6.50/share in cash. The higher offer values the deal at €200.7 million for all of the outstanding shares, Solvay says. This is a 74% premium to the closing price of April 24, 2008, the day before Solvay’s initial offer. Solvay says it raised its offer price following a €215-million bid for Innogenetics from Gen-Probe (San Diego) in June. The deal between Solvay and Inogenetics is expected to close during...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa